Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Martin Gonzalez, Javier ; Baudet, Aurélie ; Abelechian, Sahar ; Bonderup, Kasper ; d'Altri, Teresa ; Porse, Bo ; Brakebusch, Cord ; Juliusson, Gunnar ; Cammenga, Jörg. / A new genetic tool to improve immune-compromised mouse models : Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines. I: Genesis (New York, N.Y. : 2000). 2018 ; Bind 56, Nr. 9. s. e23238.

Bibtex

@article{a927331bbc3f4bf6a426f5eb05dc72a7,
title = "A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines",
abstract = "Development of human hematopoietic stem cells and differentiation of embryonic stem (ES) cells/induced pluripotent stem (iPS) cells to hematopoietic stem cells are poorly understood. NOD (Non-obese diabetic)-derived mouse strains, such as NSG (NOD-Scid-il2Rg) or NRG (NOD-Rag1-il2Rg), are the best available models for studying the function of fetal and adult human hematopoietic cells as well as ES/iPS cell-derived hematopoietic stem cells. Unfortunately, engraftment of human hematopoietic stem cells is very variable in these models. Introduction of additional permissive mutations into these complex genetic backgrounds of the NRG/NSG mice by natural breeding is a very demanding task in terms of time and resources. Specifically, since the genetic elements defining the NSG/NRG phenotypes have not yet been fully characterized, intense backcrossing is required to ensure transmission of the full phenotype. Here we describe the derivation of embryonic stem cell (ESC) lines from NRG pre-implantation embryos generated by in vitro fertilization followed by the CRISPR/CAS9 targeting of the Gata-2 locus. After injection into morula stage embryos, cells from three tested lines gave rise to chimeric adult mice showing high contribution of the ESCs (70-100{\%}), assessed by coat color. Moreover, these lines have been successfully targeted using Cas9/CRISPR technology, and the mutant cells have been shown to remain germ line competent. Therefore, these new NRG ESC lines combined with genome editing nucleases bring a powerful genetic tool that facilitates the generation of new NOD-based mouse models with the aim to improve the existing xenograft models. This article is protected by copyright. All rights reserved.",
author = "{Martin Gonzalez}, Javier and Aur{\'e}lie Baudet and Sahar Abelechian and Kasper Bonderup and Teresa d'Altri and Bo Porse and Cord Brakebusch and Gunnar Juliusson and J{\"o}rg Cammenga",
note = "This article is protected by copyright. All rights reserved.",
year = "2018",
month = "7",
day = "16",
doi = "10.1002/dvg.23238",
language = "English",
volume = "56",
pages = "e23238",
journal = "Genesis: The Journal of Genetics and Development (Online)",
issn = "1526-968X",
publisher = "JohnWiley & Sons, Inc",
number = "9",

}

RIS

TY - JOUR

T1 - A new genetic tool to improve immune-compromised mouse models

T2 - Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines

AU - Martin Gonzalez, Javier

AU - Baudet, Aurélie

AU - Abelechian, Sahar

AU - Bonderup, Kasper

AU - d'Altri, Teresa

AU - Porse, Bo

AU - Brakebusch, Cord

AU - Juliusson, Gunnar

AU - Cammenga, Jörg

N1 - This article is protected by copyright. All rights reserved.

PY - 2018/7/16

Y1 - 2018/7/16

N2 - Development of human hematopoietic stem cells and differentiation of embryonic stem (ES) cells/induced pluripotent stem (iPS) cells to hematopoietic stem cells are poorly understood. NOD (Non-obese diabetic)-derived mouse strains, such as NSG (NOD-Scid-il2Rg) or NRG (NOD-Rag1-il2Rg), are the best available models for studying the function of fetal and adult human hematopoietic cells as well as ES/iPS cell-derived hematopoietic stem cells. Unfortunately, engraftment of human hematopoietic stem cells is very variable in these models. Introduction of additional permissive mutations into these complex genetic backgrounds of the NRG/NSG mice by natural breeding is a very demanding task in terms of time and resources. Specifically, since the genetic elements defining the NSG/NRG phenotypes have not yet been fully characterized, intense backcrossing is required to ensure transmission of the full phenotype. Here we describe the derivation of embryonic stem cell (ESC) lines from NRG pre-implantation embryos generated by in vitro fertilization followed by the CRISPR/CAS9 targeting of the Gata-2 locus. After injection into morula stage embryos, cells from three tested lines gave rise to chimeric adult mice showing high contribution of the ESCs (70-100%), assessed by coat color. Moreover, these lines have been successfully targeted using Cas9/CRISPR technology, and the mutant cells have been shown to remain germ line competent. Therefore, these new NRG ESC lines combined with genome editing nucleases bring a powerful genetic tool that facilitates the generation of new NOD-based mouse models with the aim to improve the existing xenograft models. This article is protected by copyright. All rights reserved.

AB - Development of human hematopoietic stem cells and differentiation of embryonic stem (ES) cells/induced pluripotent stem (iPS) cells to hematopoietic stem cells are poorly understood. NOD (Non-obese diabetic)-derived mouse strains, such as NSG (NOD-Scid-il2Rg) or NRG (NOD-Rag1-il2Rg), are the best available models for studying the function of fetal and adult human hematopoietic cells as well as ES/iPS cell-derived hematopoietic stem cells. Unfortunately, engraftment of human hematopoietic stem cells is very variable in these models. Introduction of additional permissive mutations into these complex genetic backgrounds of the NRG/NSG mice by natural breeding is a very demanding task in terms of time and resources. Specifically, since the genetic elements defining the NSG/NRG phenotypes have not yet been fully characterized, intense backcrossing is required to ensure transmission of the full phenotype. Here we describe the derivation of embryonic stem cell (ESC) lines from NRG pre-implantation embryos generated by in vitro fertilization followed by the CRISPR/CAS9 targeting of the Gata-2 locus. After injection into morula stage embryos, cells from three tested lines gave rise to chimeric adult mice showing high contribution of the ESCs (70-100%), assessed by coat color. Moreover, these lines have been successfully targeted using Cas9/CRISPR technology, and the mutant cells have been shown to remain germ line competent. Therefore, these new NRG ESC lines combined with genome editing nucleases bring a powerful genetic tool that facilitates the generation of new NOD-based mouse models with the aim to improve the existing xenograft models. This article is protected by copyright. All rights reserved.

U2 - 10.1002/dvg.23238

DO - 10.1002/dvg.23238

M3 - Journal article

VL - 56

SP - e23238

JO - Genesis: The Journal of Genetics and Development (Online)

JF - Genesis: The Journal of Genetics and Development (Online)

SN - 1526-968X

IS - 9

ER -

ID: 54954032